Research ArticleVasculitis
Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jason M. Springer and Ryan S. Funk
The Journal of Rheumatology November 2021, 48 (11) 1718-1724; DOI: https://doi.org/10.3899/jrheum.210361
Jason M. Springer
1J.M. Springer, Associate Professor, MD, MS, Division of Rheumatology and Immunology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;
Ryan S. Funk
2R.S. Funk, Associate Professor, PharmD, PhD, Department of Pharmacy Practice, University of Kansas Medical Center, Kansas City, Kansas, USA.
REFERENCES
- 1.↵
- 2.↵
- 3.
- Charles P,
- Terrier B,
- Perrodeau E,
- Cohen P,
- Faguer S,
- Huart A, et al; French Vasculitis Study Group
- 4.↵
- Charles P,
- Perrodeau E,
- Samson M,
- Bonnotte B,
- Néel A,
- Agard C, et al; French Vasculitis Study Group
- 5.↵
- Smith R,
- Jayne D,
- Merkel P.
- 6.↵
- Cornec D,
- Kabat BF,
- Mills JR,
- Cheu M,
- Hummel AM,
- Schroeder DR, et al.
- 7.↵
- Bensalem A,
- Mulleman D,
- Paintaud G,
- Azzopardi N,
- Gouilleux-Gruart V,
- Cornec D, et al.
- 8.↵
- Springer JM,
- Kalot MA,
- Husainat NM,
- Byram KW,
- Dua AB,
- James KE, et al.
- 9.↵
- 10.↵
- Hiemstra TF,
- Walsh M,
- Mahr A,
- Savage CO,
- de Groot K,
- Harper L, et al; European Vasculitis Study Group (EUVAS)
- 11.↵
- Springer JM,
- Funk RS.
- 12.↵
- Dreesen E,
- Berends S,
- Laharie D,
- D’Haens G,
- Vermeire S,
- Gils A, et al.
- 13.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 11
1 Nov 2021
Dose-dependent Pharmacological Response to Rituximab in the Treatment of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Jason M. Springer, Ryan S. Funk
The Journal of Rheumatology Nov 2021, 48 (11) 1718-1724; DOI: 10.3899/jrheum.210361